References
- 1. Anderson SG, Gutierrez JM, Ownby CL. Comparison of the immunogenicity and antigenic composition of ten Central American snake venoms. Toxicon. 1993; 31:1051-9.10.1016/0041-0101(93)90263-I
- 2. Harrison RA, Wüster W, Theakston RD. The conserved structure of snake venom toxins confers extensive immunological cross-reactivity to toxin-specific antibody. Toxicon. 2003; 41: 441-9.10.1016/S0041-0101(02)00360-4
- 3. Stabeli RG, Magalhaes LM, Selistre-de-Araujo HS, Oliveira EB. Antibodies to a fragment of the Bothrops moojenil-amino acid oxidase cross-react with snake venom components unrelated to the parent protein. Toxicon. 2005; 46: 308-17.10.1016/j.toxicon.2005.04.020
- 4. Minton SA, Weinstein SA, Wilde CE 3rd. An enzymelinked immunoassay for detection of North American pit viper venoms. J Toxicol Clin Toxicol. 1984; 22:303-16.10.3109/15563658408992562
- 5. Theakston RD. The application of immunoassay techniques, including enzyme-linked immunosorbent assay (ELISA), to snake venom research. Toxicon. 1983; 21:341-52.10.1016/0041-0101(83)90090-9
- 6. Barral-Netto M, Schriefer A, Barral A, Almeida AR, Mangabeira A. Serum levels of bothropic venom in patients without anti-venom intervention. Am J Trop Med Hyg. 1991; 45: 751-4.
- 7. Gutiérrez JM, Sanz L, Flores-Diaz M, Figueroa L, Madrigal M, Herrera M, et al. Impact of regional variation in Bothrops asper snake venom on the design of antivenoms: integrating antivenomics and neutralization approaches. J Proteome Res. 2010; 9:564-77.10.1021/pr9009518
- 8. Hanashiro MA, Da Silva MH, Bier OG. Neutralization of crotoxin and crude venom by rabbit antiserum to crotalus phospholipase A. Immunochemistry. 1978; 15:745-50.10.1016/0161-5890(78)90103-7
- 9. Kaiser II, Middlebrook JL, Crumrine MH, Stevenson WW. Cross-reactivity and neutralization by rabbit antisera raised against crotoxin, its subunits and two related toxins. Toxicon. 1986; 24: 669-78.10.1016/0041-0101(86)90030-9
- 10. Gowda DC, Jackson CM, Hensley P, Davidson, EA. Factor X-activating glycoprotein of Russell’s viper venom. Polypeptide composition and characterization of the carbohydrate moieties. J Biol Chem. 1994; 269:10644-50.
- 11. Fujikawa K, Legaz ME, Davie EW. Bovine factor X 1 (Stuart factor). Mechanism of activation by protein from Russell’s viper venom. Biochemistry. 1972; 11:4892-99.10.1021/bi00776a003
- 12. Di Scipio RG, Hermodson MA, Davie EW. Activation of human factor X (Stuart factor) by a protease from Russell’s viper venom. Biochemistry. 1977; 16:5253-60.10.1021/bi00643a015
- 13. Rungsiwongse J, Ratanabanangkoon K. Development of an ELISA to assess the potency of horse therapeutic anti-venom against Thai cobra venom. J Immunol Methods. 1991; 136: 37-43.
- 14. LeammLi UK. Cleavage of structure proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227: 680-5.
- 15. Suntravat M, Nuchprayoon I, Perez JC. Comparative study of anticoagulant and procoagulant properties of 28 snake venoms from families Elapidae, Viperidae, and purified Russell’s viper venom-factor X activator (RVV-X). Toxicon 2010; 56: 544-53.10.1016/j.toxicon.2010.05.012
- 16. Hu YX, Guo JY, Shen L, Chen Y, Zhang ZC, Zhang YL. Get effective polyclonal antisera in one month. Cell Res. 2002; 12: 157-60.10.1038/sj.cr.7290122
- 17. Morita T. Proteases which activate factor X. In: Bailey G ed. Enzymes from Snake Venoms. Fort Collins: Alaken; 1998. p. 179-209.
- 18. Kroon DJ, Baldwin-Ferro A, Lalan P. Identification of sites of degradation in a therapeutic monoclonal antibody by peptide mapping. Pharm Res. 1992; 9:1386-93.10.1023/A:1015894409623
- 19. Jia LG, Shimokawa K, Bjarnason JB, Fox JW. Snake venom metalloproteinases: structure, function and relationship to the ADAMs family of proteins. Toxicon. 1996; 34: 1269-76.10.1016/S0041-0101(96)00108-0
- 20. Ramos OH, Selistre-de-Araujo HS. Snake venom metalloproteases-structure and function of catalytic and disintegrin domains. Comp Biochem Physiol C Toxicol Pharmacol. 2006; 142: 328-46.
- 21. Fox JW, Serrano SM. Insights into and speculations about snake venom metalloproteinase (SVMP) synthesis, folding and disulfide bond formation and their contribution to venom complexity. FEBS J. 2008; 275: 3016-30.
- 22. Lu Q, Navdaev A, Clemetson JM, Clemetson KJ. Snake venom C-type lectins interacting with platelet receptors. Structure-function relationships and effects on haemostasis. Toxicon. 2005; 45: 1089-98.10.1016/j.toxicon.2005.02.022
- 23. Morita T. Structures and functions of snake venom CLPs (C-type lectin-like proteins) with anticoagulant, procoagulant, and platelet-modulating activities. Toxicon. 2005; 45: 1099-114.10.1016/j.toxicon.2005.02.021
- 24. Hsu CC, Wu WB, Huang TF. A snake venom metalloproteinase, kistomin, cleaves platelet glycoprotein VI and impairs platelet functions. J Thromb Haemost. 2008; 6: 1578-85.
- 25. Andrews RK, Gardiner EE, Asazuma N, Berlanga O, Tulasne D, Nieswandt B, et al. A novel viper venom metalloproteinase, alborhagin, is an agonist at the platelet collagen receptor GPVI. J Biol Chem. 2001; 276:28092-7.
- 26. Wijeyewickrema LC, Gardiner EE, Moroi M, Berndt MC, Andrews RK. Snake venom metalloproteinases, crotarhagin and alborhagin, induce ectodomain shedding of the platelet collagen receptor, glycoprotein VI. Thromb Haemost. 2007; 98: 1285-90.
- 27. Dambisya YM, Lee TL, Gopalakrishnakone P. Action of Calloselasma rhodostoma (Malayan pit viper) venom on human blood coagulation and fibrinolysis using computerized thromboelastography (CTEG). Toxicon. 1994; 32: 1619-26.10.1016/0041-0101(94)90320-4
- 28. Yamada D, Sekiya F, Morita T. Prothrombin and factor X activator activities in the venoms of Viperidae snakes. Toxicon. 1997; 35: 1581-9.10.1016/S0041-0101(97)00043-3
- 29. Hofmann H, Bon C. Blood coagulation induced by the venom of Bothrops atrox. 2. Identification, purification, and properties of two factor X activators. Biochemistry. 1987; 26: 780-7.10.1021/bi00377a019
- 30. Nahas L, Kamiguti AS, Barros MA. Thrombin-like and factor X-activator components of Bothrops snake venoms. Thromb Haemost. 1979;41: 314-28.
- 31. Komori Y, Nikai T, Sugihara H. Isolation and characterization of factor X activator from the venom of Vipera aspis aspis. Int J Biochem. 1990; 22: 1053-60.10.1016/0020-711X(90)90013-S
- 32. Samel M, Siigur J. Medium molecular weight factor X activating enzyme from Vipera berus berus venom. Toxicon. 1995; 33: 41-52.10.1016/0041-0101(94)00143-V
- 33. Franssen JH, Janssen-Claessen T, Van Dieijen G. Purification and properties of an activating enzyme of blood clotting factor X from the venom of Cerastes cerastes. Biochim Biophys Acta. 1983; 747: 186-90.
- 34. Farid T, Nasser H, Zaki K, el-Asmar MF. Low molecular weight factor X activator from Cerastes vipera (Sahara sand viper) venom. Toxicon. 1993; 31:1007-17.10.1016/0041-0101(93)90260-P
- 35. Chung CH, Peng HC, Huang TF. Aggretin, a C-type lectin protein, induces platelet aggregation via integrin alpha(2)beta(1) and GPIb in a phosphatidylinositol 3-kinase independent pathway. Biochem Biophys Res Commun. 2001; 285: 689-95.
- 36. Navdaev A, Clemetson JM, Polgar J, Kehrel BE, Glauner M, Magnenat E, et al. Aggretin, a heterodimeric C-type lectin from Calloselasma rhodostoma (malayan pit viper), stimulates platelets by binding to alpha 2beta 1 integrin and glycoprotein Ib, activating Syk and phospholipase Cgamma 2, but does not involve the glycoprotein VI/Fc receptor gamma chain collagen receptor. J Biol Chem. 2001; 276: 20882-9.
- 37. Peng M, Lu W, Kirby EP. Alboaggregin-B: a new platelet agonist that binds to platelet membrane glycoprotein Ib. Biochemistry. 1991; 30: 11529-36.10.1021/bi00113a007
- 38. Yoshida E, Fujimura Y, Miura S, Sugimoto M, Fukui H, Narita N, et al. Alboaggregin-B and botrocetin, two snake venom proteins with highly homologous amino acid sequences but totally distinct functions on von Willebrand factor binding to platelets. Biochem Biophys Res Commun. 1993; 191: 1386-92.
- 39. Usami Y, Suzuki M, Yoshida E, Sakurai Y, Hirano K, Kawasaki T, et al. Primary structure of alboaggregin-B purified from the venom of Trimeresurus albolabris. Biochem Biophys Res Commun. 1996; 219: 727-33.